Renal replacement therapy (RRT) is therapy that replaces the normal blood-filtering function of the kidneys. It is used when the kidneys are not working well, which is called kidney failure and includes acute kidney injury and chronic kidney disease. Renal replacement therapy includes dialysis (hemodialysis or peritoneal dialysis), hemofiltration, and hemodiafiltration, which are various ways of filtration of blood with or without machines. Renal replacement therapy also includes kidney transplantation, which is the ultimate form of replacement in that the old kidney is replaced by a donor kidney.
This report contains market size and forecasts of Renal Replacement and End Stage Renal Disease Therapy in Global, including the following market information:
Global Renal Replacement and End Stage Renal Disease Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Renal Replacement and End Stage Renal Disease Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Renal Replacement and End Stage Renal Disease Therapy include Fresenius, DaVita, Baxter, US rental care, B.Braun, Diaverum, Nipro, Asahi Kasei and Nikkiso, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Replacement and End Stage Renal Disease Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Replacement and End Stage Renal Disease Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Renal Replacement and End Stage Renal Disease Therapy Market Segment Percentages, by Type, 2021 (%)
Devices
Consumables
Services
Global Renal Replacement and End Stage Renal Disease Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Renal Replacement and End Stage Renal Disease Therapy Market Segment Percentages, by Application, 2021 (%)
Hospital
Dialysis Center
Other
Global Renal Replacement and End Stage Renal Disease Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Renal Replacement and End Stage Renal Disease Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Replacement and End Stage Renal Disease Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Renal Replacement and End Stage Renal Disease Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fresenius
DaVita
Baxter
US rental care
B.Braun
Diaverum
Nipro
Asahi Kasei
Nikkiso
Toray
WEGO
JMS
Medtronic
SWS Hemodialysis Care